How does Sitagliptin impact the progression of diabetes-related kidney diseases, particularly in preserving renal function?
Sunil JoshiExplorer
How does Sitagliptin impact the development of diabetes-related kidney diseases?
Share
Sitagliptin, a DPP-4 inhibitor, may slow the progression of diabetic nephropathy by reducing albuminuria and improving glycemic control, thus potentially preserving renal function.